...
bcda-img

Biocardia Inc, Common Stock

BCDA

NAQ

$2.045

-$0.05

(-2.38%)

1D
Industry: Biotechnology Sector: Health Care

Analyst Forecast

Price Chart

Key Metrics

Market Cap info-icon
This is a company’s total value as determined by the stock market. It is calculated by multiplying the total number of a company's outstanding shares by the current market price of one share.
$9.63M
P/E Ratio info-icon
This is the ratio of a security’s current share price to its earnings per share. This ratio determines the relative value of a company’s share.
0
Volume info-icon
This is the total number of shares traded during the most recent trading day.
16.64K
Avg Volume info-icon
This is the average number of shares traded during the most recent 30 days.
0
Dividend Yield info-icon
This ratio shows how much income you earn in dividend payouts per year for every dollar invested in the stock (or the stock’s annual dividend payment expressed as a percentage of its current price).
0.00%
Beta info-icon
This measures the expected move in a stock’s price relative to movements in the overall market. The market, such as the S&P 500 Index, has a beta of 1.0. If a stock has a Beta greater (or lower) than 1.0, it suggests that the stock is more (or less) volatile than the broader market.
1.27
52-week Range info-icon
This shows the range of the stock’s price between the 52-week high (the highest price of the stock for the past 52 weeks) and the 52-week low (the lowest price of the stock for the past 52 weeks).
$1.84 L
$10.79 H
$2.045

About Biocardia Inc, Common Stock

BioCardia, Inc., a clinical-stage regenerative medicine company, develops cellular and cell-derived therapeutics for cardiovascular and pulmonary diseases in the United States. Its lead product candidate is CardiAMP, an autologous mononuclear cell therapy system in Phase III clinical trial for the treatment of ischemic heart failure with reduced ejection fraction and refractory angina resulting from chronic myocardial ischemia. The company is also developing an allogeneic cells therapy platform, which is an investigational culture expanded bone marrow derived mesenchymal cell therapy in Phase I/II trial to treat ischemic heart failure and acute respiratory distress syndrome. In addition, it offers the Helix biotherapeutic delivery system for minimally invasive targeted delivery of biologic agents to the heart; and Morph deflectable guides and sheaths. The company has collaboration agreements with CellProthera in the development of ProtheraCytes, which is currently under Phase II trial for the treatment of acute myocardial infarction. BioCardia, Inc. is based in Sunnyvale, California. more

Industry: BiotechnologySector: Health Care

Returns

Time FrameBCDASectorS&P500
1-Week Return-7.49%-3.39%0.2%
1-Month Return2.43%-1.92%2.72%
3-Month Return-24.73%-10.54%7.31%
6-Month Return-37.13%-4.47%10.44%
1-Year Return-78.5%4.06%27.53%
3-Year Return-92%0.94%30.88%
5-Year Return-96.27%36.67%89.21%
10-Year Return-98.71%102.87%199.95%

Financials

Dec '19Dec '20Dec '21Dec '22Dec '235YR TREND
Total Revenue710.00K145.00K1.01M1.35M477.00K[{"date":"2019-12-31","value":52.51,"profit":true},{"date":"2020-12-31","value":10.72,"profit":true},{"date":"2021-12-31","value":75.07,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":35.28,"profit":true}]
Cost of Revenue358.00K4.00K640.00K11.90M7.73M[{"date":"2019-12-31","value":3.01,"profit":true},{"date":"2020-12-31","value":0.03,"profit":true},{"date":"2021-12-31","value":5.38,"profit":true},{"date":"2022-12-31","value":100,"profit":true},{"date":"2023-12-31","value":64.92,"profit":true}]
Gross Profit352.00K141.00K375.00K(10.55M)(7.25M)[{"date":"2019-12-31","value":93.87,"profit":true},{"date":"2020-12-31","value":37.6,"profit":true},{"date":"2021-12-31","value":100,"profit":true},{"date":"2022-12-31","value":-2813.07,"profit":false},{"date":"2023-12-31","value":-1933.07,"profit":false}]
Gross Margin49.58%97.24%36.95%(780.25%)(1519.71%)[{"date":"2019-12-31","value":50.98,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":37.99,"profit":true},{"date":"2022-12-31","value":-802.39,"profit":false},{"date":"2023-12-31","value":-1562.82,"profit":false}]
Operating Expenses14.56M15.67M13.64M13.25M12.12M[{"date":"2019-12-31","value":92.95,"profit":true},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":87.08,"profit":true},{"date":"2022-12-31","value":84.58,"profit":true},{"date":"2023-12-31","value":77.35,"profit":true}]
Operating Income(14.21M)(15.53M)(12.63M)(11.90M)(11.64M)[{"date":"2019-12-31","value":-1421300000,"profit":false},{"date":"2020-12-31","value":-1552900000,"profit":false},{"date":"2021-12-31","value":-1263000000,"profit":false},{"date":"2022-12-31","value":-1190100000,"profit":false},{"date":"2023-12-31","value":-1164400000,"profit":false}]
Total Non-Operating Income/Expense(521.00K)543.00K16.00K--[{"date":"2019-12-31","value":-95.95,"profit":false},{"date":"2020-12-31","value":100,"profit":true},{"date":"2021-12-31","value":2.95,"profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Pre-Tax Income(14.71M)(15.00M)(12.62M)(11.91M)(11.57M)[{"date":"2019-12-31","value":-1470900000,"profit":false},{"date":"2020-12-31","value":-1500400000,"profit":false},{"date":"2021-12-31","value":-1262300000,"profit":false},{"date":"2022-12-31","value":-1190700000,"profit":false},{"date":"2023-12-31","value":-1157100000,"profit":false}]
Income Taxes110.00K1.00K(2.00K)6.00K243.10K[{"date":"2019-12-31","value":45.25,"profit":true},{"date":"2020-12-31","value":0.41,"profit":true},{"date":"2021-12-31","value":-0.82,"profit":false},{"date":"2022-12-31","value":2.47,"profit":true},{"date":"2023-12-31","value":100,"profit":true}]
Income After Taxes(14.82M)(15.01M)(12.62M)--[{"date":"2019-12-31","value":-1481900000,"profit":false},{"date":"2020-12-31","value":-1500500000,"profit":false},{"date":"2021-12-31","value":-1262100000,"profit":false},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Income From Continuous Operations(14.71M)(15.00M)(12.62M)(11.91M)(11.57M)[{"date":"2019-12-31","value":-1470900000,"profit":false},{"date":"2020-12-31","value":-1500400000,"profit":false},{"date":"2021-12-31","value":-1262300000,"profit":false},{"date":"2022-12-31","value":-1190700000,"profit":false},{"date":"2023-12-31","value":-1157100000,"profit":false}]
Income From Discontinued Operations-----[{"date":"2019-12-31","value":"-","profit":true},{"date":"2020-12-31","value":"-","profit":true},{"date":"2021-12-31","value":"-","profit":true},{"date":"2022-12-31","value":"-","profit":true},{"date":"2023-12-31","value":"-","profit":true}]
Net Income(14.82M)(15.01M)(12.62M)(11.91M)(11.57M)[{"date":"2019-12-31","value":-1481900000,"profit":false},{"date":"2020-12-31","value":-1500500000,"profit":false},{"date":"2021-12-31","value":-1262100000,"profit":false},{"date":"2022-12-31","value":-1191300000,"profit":false},{"date":"2023-12-31","value":-1157100000,"profit":false}]
EPS (Diluted)(2.73)(1.39)(0.74)(0.67)(0.55)[{"date":"2019-12-31","value":-273,"profit":false},{"date":"2020-12-31","value":-139,"profit":false},{"date":"2021-12-31","value":-74,"profit":false},{"date":"2022-12-31","value":-67,"profit":false},{"date":"2023-12-31","value":-55,"profit":false}]

Ratios

Liquidity

These ratios help you determine the liquidity of the company. Higher is better.

BCDA
Cash Ratio 1.74
Current Ratio 1.78

Asset Efficiency

These ratios help you understand the company's efficiency in using its assets to generate returns. Higher is better. For ROE, average long term is around 14%, less than 10% is poor.

BCDA
ROA (LTM) -115.93%
ROE (LTM) -703.62%

Liabilities

These ratios help you understand the company's liabilities, gauging the riskiness of the investment.

BCDA
Debt Ratio Lower is generally better. Negative is bad. 0.56
Common Equity/Total Assets Higher is better. Lower can suggest investment is riskier. 0.44

Valuation

These ratios help you understand the company's valuation. Lower may indicate cheaper stocks.

BCDA
Trailing PE NM
Forward PE NM
P/S (TTM) 22.49
P/B 3.50
Price/FCF NM
EV/R 80.87
EV/Ebitda NM
PEG NM

FAQs

What is Biocardia Inc share price today?

Biocardia Inc (BCDA) share price today is $2.045

Can Indians buy Biocardia Inc shares?

Yes, Indians can buy shares of Biocardia Inc (BCDA) on Vested. To buy Biocardia Inc from India, you can open a US Brokerage account on Vested today by clicking on Sign Up or Invest in BCDA stock at the top of this page. The account opening process is completely digital and secure, and takes a few minutes to complete.

Can Fractional shares of Biocardia Inc be purchased?

Yes, you can purchase fractional shares of Biocardia Inc (BCDA) via the Vested app. You can start investing in Biocardia Inc (BCDA) with a minimum investment of $1.

How to invest in Biocardia Inc shares from India?

You can invest in shares of Biocardia Inc (BCDA) via Vested in three simple steps:

  • Click on Sign Up or Invest in BCDA stock at the top of this page
  • Breeze through our fully digital and secure KYC process and open your US Brokerage account in a few minutes
  • Transfer USD funds to your US Brokerage account and start investing in Biocardia Inc shares
What is Biocardia Inc 52-week high and low stock price?

The 52-week high price of Biocardia Inc (BCDA) is $10.79. The 52-week low price of Biocardia Inc (BCDA) is $1.84.

What is Biocardia Inc price-to-earnings (P/E) ratio?

The price-to-earnings (P/E) ratio of Biocardia Inc (BCDA) is

What is Biocardia Inc price-to-book (P/B) ratio?

The price-to-book (P/B) ratio of Biocardia Inc (BCDA) is 3.50

What is Biocardia Inc dividend yield?

The dividend yield of Biocardia Inc (BCDA) is 0.00%

What is the Market Cap of Biocardia Inc?

The market capitalization of Biocardia Inc (BCDA) is $9.63M

What is Biocardia Inc’s stock symbol?

The stock symbol (or ticker) of Biocardia Inc is BCDA

Signup to access all features and start your US investing journey!

  • Open your account in minutes
  • Take your portfolio global, starting at just $1
Get started

Add ticker to compare

Scroll to Top